1. Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies

   • Shazia K. Nakhoda
   • Anthony J. Olszanski

   Leading Article 10 March 2020 Pages: 83 - 91

   

2. Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products

   • Bryan Newman
   • Kimberly Witzmann

   Review Article 28 February 2020 Pages: 93 - 102

   

3. Critical Factors Shaping Strategy Development of an Innovative Medicine in Oncology

   • Andriy Krendyukov
   • Sreekanth Gattu

   Review Article 27 February 2020 Pages: 103 - 112

   

4. Proposal for a New Stereochemically Informative Nonproprietary Drug Naming System

   • Joseph Gal

   Original Research Article 19 February 2020 Pages: 113 - 126

   

5. Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers

   • Ravi Jandhyala

   Original Research Article Open access 09 January 2020 Pages: 127 - 134

   

6. US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)

   • Thomas J. Moore
   • Richard L. Morrow
   • Barbara Mintzes

   Original Research Article 16 March 2020 Pages: 135 - 140

   

7. Forum

   Update 07 March 2020 Pages: 141 - 154

8. Major Pharmaceutical Conferences and Courses

   Update 09 March 2020 Pages: 155 - 157